Chief Medical Officer, NattoPharma ASA
Hogne Vik, MD, PhD, MBA, serves as the Chief Medical Officer with NattoPharma ASA. A physician by education, he has a long and successful track record in both the pharmaceutical and dietary supplement industries. Prior to joining NattoPharma, Dr. Vik was the driving force behind the documentation program securing the current marketing position of Superba Krill Oil developed and manufactured by Aker BioMarine Antarctic. He was one of the key executives in the management team of Pronova BioPharma securing the US and Japanese market entrances of Omacor/Lovaza, and was instrumental in bringing Tonalin (CLA) to the European and US markets as part of Natural ASA. Additionally, as Global Vice President of Product Development with Nycomed, Dr. Vik was one of the main forces behind the development of VisiPaque.